Evidence map›Paper›PMID 31277500›Full record

ArticleNutrients2019

Selenized Plant Oil Is an Efficient Source of Selenium for Selenoprotein Biosynthesis in Human Cell Lines.

Jordan Sonet, Maurine Mosca, Katarzyna Bierla, Karolina Modzelewska, Anna Flis-Borsuk, Piotr Suchocki, Iza Ksiazek, Elzbieta Anuszewska, Anne-Laure Bulteau, Joanna Szpunar and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Selenium Compounds as Novel Potential Anticancer Agents.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jordan SonetCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Maurine MoscaCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Katarzyna BierlaCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Karolina ModzelewskaCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Anna Flis-BorsukCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Piotr SuchockiDepartment of Bioanalysis and Analysis of Drugs, Medical University of Warsaw, Żwirki i Wigury 81, 02-091 Warszawa, Poland.
Iza KsiazekDepartment of Biochemistry and Biopharmaceuticals, National Medicines Institute, Chelmska 30/34, PL-00-725 Warszawa, Poland.ORCID 0000-0002-4315-6991
Elzbieta AnuszewskaDepartment of Biochemistry and Biopharmaceuticals, National Medicines Institute, Chelmska 30/34, PL-00-725 Warszawa, Poland.
Anne-Laure BulteauCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Joanna SzpunarCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Ryszard LobinskiCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France.
Laurent ChavatteCNRS/UPPA, Institute of Analytical and Physical Chemistry for the Environment and Materials (IPREM), UMR5254, Hélioparc, F-64053 Pau, France. laurent.chavatte@ens-lyon.fr.ORCID 0000-0001-7696-2431
Centre National de la Recherche Scientifique · FRNarodowy Instytut Leków · PLMedical University of Warsaw · PLUniversité Claude Bernard Lyon 1 · FR

Funding

Agence Nationale de la Recherche ANR-09-BLAN-0048Centre National de la Recherche Scientifique ATIP program LCEcole normale supérieure de Lyon ENS de Lyon Emerging ProjectInstitut National de la Santé et de la Recherche Médicale INSERMUniversité de Pau et des Pays de l'Adour UPPA
6 · The paper itself

Abstract

Selenium is an essential trace element which is incorporated in the form of a rare amino acid, the selenocysteine, into an important group of proteins, the selenoproteins. Among the twenty-five selenoprotein genes identified to date, several have important cellular functions in antioxidant defense, cell signaling and redox homeostasis. Many selenoproteins are regulated by the availability of selenium which mostly occurs in the form of water-soluble molecules, either organic (selenomethionine, selenocysteine, and selenoproteins) or inorganic (selenate or selenite). Recently, a mixture of selenitriglycerides, obtained by the reaction of selenite with sunflower oil at high temperature, referred to as Selol, was proposed as a novel non-toxic, highly bioavailable and active antioxidant and antineoplastic agent. Free selenite is not present in the final product since the two phases (water soluble and oil) are separated and the residual water-soluble selenite discarded. Here we compare the assimilation of selenium as Selol, selenite and selenate by various cancerous (LNCaP) or immortalized (HEK293 and PNT1A) cell lines. An approach combining analytical chemistry, molecular biology and biochemistry demonstrated that selenium from Selol was efficiently incorporated in selenoproteins in human cell lines, and thus produced the first ever evidence of the bioavailability of selenium from selenized lipids.

Indexed as

Cell Line, TumorHEK293 CellsHumansPlant OilsSelenic AcidSelenious AcidSelenium CompoundsSelenoproteinsTriglyceridesPlant OilsSelenic AcidSelenious AcidSelenium CompoundsSelenoproteinsselolTriglyceridesGpx1Gpx4ICP-MSseleniumselenized lipidsselenoproteinSelolTxnrd1Txnrd2

Identifiers

PMID31277500
PMCPMC6682991
OpenAlexW2953638677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.